Evidence map›Paper›PMID 39309851›Full record

ArticleHeliyon2024

Diffuse skin erythematous plaque as a manifestation of epithelioid hemangioendothelioma: A case report.

Ruoxin Pan, Chuang Wang, Duoduo Gu, Xiaoqi Meng, Tingwei Liu, Hui Zhong, Qixing Gong, Yang Xu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ruoxin PanDepartment of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Chuang WangDepartment of Dermatology, Taizhou Hospital of Traditional Chinese Medicine, Taizhou, 225300, China.
Duoduo GuDepartment of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Xiaoqi MengDepartment of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Tingwei LiuDepartment of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Hui ZhongState Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
Qixing GongDepartment of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Yang XuDepartment of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epithelioid hemangioma (EHE) is a rarely malignant tumor originating from the vascular endothelium. Morphological manifestations and immunohistochemical staining results are key to diagnosing EHE. Herein, we present a case of cutaneous involment in a recurrence of EHE. A 75-year-old woman presented with a month-long history of persistent erythematous plaque and pain in the left shoulder. Skin biopsy specimen revealed epithelioid tumor cells containing abundant eosinophilic cytoplasm. Immunohistochemical staining confirmed a recurrence of EHE involving the skin. Subsequently, recombinant human endostatin was administered. At the 10-day follow-up, the cutaneous plaque had improved, and the pain had resolved. When presenting as a local painful erythematous plaque, the possibility of skin involvement in a malignant tumor should be considered. Early diagnosis and early systemic therapy have an important impact on the overall survival of patients with EHE.

Indexed as

Case reportEpithelioid hemangioendotheliomaSkin neoplasmsWWTR1-CAMTA1

Identifiers

PMID39309851
PMCPMC11416294

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.